Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma
- PMID: 263348
- DOI: 10.1210/jcem-47-6-1257
Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma
Similar articles
-
Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.Cancer Res. 1982 Aug;42(8 Suppl):3349s-3352s. Cancer Res. 1982. PMID: 7083199
-
Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.Breast Cancer Res Treat. 1986;7 Suppl:S23-35. Breast Cancer Res Treat. 1986. PMID: 3527304 Clinical Trial.
-
Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels.J Clin Endocrinol Metab. 1977 Sep;45(3):480-7. doi: 10.1210/jcem-45-3-480. J Clin Endocrinol Metab. 1977. PMID: 903399 No abstract available.
-
Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.J Steroid Biochem. 1990 Mar;35(3-4):355-66. doi: 10.1016/0022-4731(90)90241-j. J Steroid Biochem. 1990. PMID: 2139151 Review.
-
Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.J Clin Invest. 1980 Mar;65(3):602-12. doi: 10.1172/JCI109705. J Clin Invest. 1980. PMID: 6986409 Free PMC article. Review.
Cited by
-
The discovery and mechanism of action of letrozole.Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):7-17. doi: 10.1007/s10549-007-9696-3. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912633 Free PMC article. Review.
-
Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment.Breast Cancer Res Treat. 1992;23(1-2):57-62. doi: 10.1007/BF01831476. Breast Cancer Res Treat. 1992. PMID: 1446052 Clinical Trial.
-
Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.Br J Cancer. 1991 Nov;64(5):887-94. doi: 10.1038/bjc.1991.420. Br J Cancer. 1991. PMID: 1931611 Free PMC article. Clinical Trial.
-
Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.Br J Cancer. 1983 Oct;48(4):595-8. doi: 10.1038/bjc.1983.233. Br J Cancer. 1983. PMID: 6688732 Free PMC article. No abstract available.
-
Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment.Breast Cancer Res Treat. 1981;1(2):91-5. doi: 10.1007/BF01805860. Breast Cancer Res Treat. 1981. PMID: 7348572
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources